We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

83 hedge funds and large institutions have $80.6M invested in CapForce IBD 50 ETF in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more call options, than puts

Call options by funds: $331K | Put options by funds: $325K

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 8483 (-1)

3.96% less ownership

Funds ownership: 27.51%23.55% (-4%)

47% less capital invested

Capital invested by funds: $153M → $80.6M (-$72.4M)

61% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 36

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
83
Holders Change
-1
Holders Change %
-1.19%
% of All Funds
1.85%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
14
Reduced
36
Closed
21
Calls
$331K
Puts
$325K
Net Calls
+$6K
Net Calls Change
-$125K
Name Holding Trade Value Shares
Change
Change in
Stake
WOC
101
West Oak Capital
California
-$13.5K -350 Closed
GRP
102
Global Retirement Partners
California
-$8K -200 Closed
Parallax Volatility Advisers
103
Parallax Volatility Advisers
California
-$3K -86 Closed
Fidelity Investments
104
Fidelity Investments
Massachusetts
+$31 +1 New

FFTY Hedge Fund Activity: Q4 2018 in Review

83 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q4 2018, worth a combined $80.6M — down 47% from $153M a quarter earlier.

Fund positioning in FFTY was balanced in Q4 2018: 21 funds opened new positions, 21 closed out, 14 added to existing stakes and 36 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $2.41M. The largest seller was UBS Group, cutting an estimated $8.65M.

  • 83 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q4 2018, down from 84 in Q3 2018.
  • Funds reported $80.6M of CapForce IBD 50 ETF stock for Q4 2018, down 47% quarter-over-quarter.
  • 21 funds opened new CapForce IBD 50 ETF positions in Q4 2018 and 21 closed out, a net change of 0 holders.
  • The largest CapForce IBD 50 ETF buyer in Q4 2018 was Tower Research Capital (TRC), an estimated $2.41M added.
  • The largest CapForce IBD 50 ETF seller in Q4 2018 was UBS Group, an estimated $8.65M sold.

Based on aggregated 13F filings for Q4 2018.